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Received June 14, 2013; accepted January 8, 2014AbstractBackground: Little is known about the impact of severe carotid stenosis on health-related quality of life (HRQoL). The aim of this study was to
assess the effects of carotid stenting (CAS) on HRQoL in dizzy patients with carotid stenosis.
Methods: Patients with symptomatic (60%) or asymptomatic (80%) severe carotid stenosis and who complained of dizziness and received
CAS were recruited. Two HRQoL questionnairesda generic survey, the 36-item Short-Form Health Survey and a disease-specific instrument,
the Dizziness Handicap Inventorydserved as outcome measures. Patients were followed 1 week prior to CAS and 6 months postprocedurally.
Results: CAS was performed in 178 consecutive patients, 61 of whom complained of dizziness. Forty-one patients (67.2%, 34 male; mean age,
73.3 ± 10.5 years; range, 47e87 years) completed the study. Twenty asymptomatic volunteers (17 male; mean age, 70.3 ± 9.3 years; range,
54e84 years) served as normal controls. Compared to controls, patients tallied lower scores in the overall total and three subscales (physical,
functional, and emotional) of the Dizziness Handicap Inventory (p < 0.01). Similar findings were noted in seven out of eight domains of the 36-
item Short-Form Health Survey score. After 6 months, CAS resulted in significantly improved HRQoL (role physical, bodily pain, general
health, social function, and role emotional) in these patients.
Conclusion: CAS resulted in improved HRQoL in patients with severe carotid stenosis who experienced dizziness.
Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Dizziness is a common complaint in the general popula-
tion.1 Of the various etiologies, vestibular or psychiatric cau-
ses account for more than 70% of dizziness.2 Cardiovascular
and cerebrovascular diseases are common nonvestibular cau-
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1726-4901/Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical Asswell-known cause of vertebrobasilar disorders, carotid stenosis
may also play a role in the genesis of dizziness. Weinberger
et al4 found that out of 101 patients complaining of nonspecific
dizziness, 21 had hemodynamically significant carotid steno-
sis. Similar results have been reported by other authors.5,6 This
might imply that the symptoms of dizziness may result from
decreased cerebral perfusion due to carotid artery occlusive
disease in some patients complaining of dizziness. Carotid
revascularization, such as through carotid stenting (CAS), has
emerged as a potential therapeutic alternative in patients with
severe carotid stenosis for the prevention of recurrent ischemic
events.7,8 However, the role of such revascularization in pa-
tients with dizziness is still unclear. In addition, little is known
about the impact of CAS on quality of life.ociation. All rights reserved.
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considerable impairment in daily functioning and jeopardize
personal, professional, social, and leisure activities. Accord-
ingly, in order to manage these patients adequately, it is
important to assess the impact of dizziness on everyday life.
Therefore, the objectives of the present research were: (1)
to assess dizziness-related impairment upon quality of life in
patients with severe carotid stenosis; and (2) to see if CAS can
result in improved health-related quality of life (HRQoL) in
these patients.
2. Methods2.1. Study populationThis study was conducted in a tertiary referral hospital in
northern Taipei, Taiwan, R.O.C. Patients with a chief
complaint of nonspecific dizziness, e.g., feelings of giddiness,
imbalance, light-headedness, a sensation of impending faint,
for >1 month and/or minor stroke using the modified Rankin
scale 2 prior to entry or transient ischemic attack (TIA)
referred to the hospital's neurovascular laboratory for
screening of carotid stenosis were invited to participate in the
study. Patients were deemed to be suitable candidates if they
met the following criteria: (1) evidence of unilateral extra-
cranial carotid stenosis 60%, if they were symptomatic
(history of old minor stroke/TIA in addition to dizziness
complaints) or  80% if they were considered asymptomatic
(complained of dizziness alone); and (2) complete 6-month
follow-up data were available. Patients were excluded if they
had: (1)  50% stenosis or occlusion of contralateral carotid
artery or the vertebra-basilar arteries; (2)  50% stenosis of
the intracranial arteries; (3) hemorrhagic or brainstem strokes;
(4) history of overt causes of dizziness or vertigo, such as
peripheral vestibular dysfunction; (5) other causes of dizziness
or unsteadiness such as cardiovascular medications, central or
peripheral neurological disorders, cardiopulmonary, or
musculoskeletal or psychiatric diseases; (6) previous history of
carotid endarterectomy, angioplasty, or stenting; or (7) carotid
dissection or radiation angiopathy. In addition, 20 sex- and
age-matched asymptomatic individuals of our general
neurology outpatient department free of dizziness and carotid
stenosis (17 male; mean age, 70.3 ± 9.3 years; range, 54e84
years) served as normal controls. The study hospital's Insti-
tutional Review Board approved the study protocol and each
participant provided signed informed consent prior to entering
the study.2.2. Diagnosis of carotid stenosisThe investigations of the extracranial neck vessels were
performed by an experienced technician using a two-
dimensional color Duplex ultrasound scanner (Acuson
128XP; Acuson, Mountain View, CA, USA). The diagnosis of
carotid stenosis was first made by duplex ultrasound with a 7.5-
MHz pulsed-wave transducer for extracranial examination
modified from the study by Grant et al.9 The degree of carotidstenosis was ultimately confirmed by diagnostic cerebral angi-
ography during CAS based on the North American Symptom-
atic Carotid Endarterectomy Trial (NASCET) criteria.102.3. Protocol for CASPremedication for CAS included a combination of aspirin
(100 mg/day) and clopidogrel (75 mg/day), started at least 3
days prior to CAS. During the procedure, a transfemoral
arterial approach was used to obtain a complete angiogram of
the supra-aortic arteries and their branches, including bilateral
carotid, bilateral vertebral, and bilateral subclavian arteries. A
6F guiding sheath (Shuttle sheath, Cook Co. Bloomington, IN,
USA) was placed into the proximal common carotid artery.
Through the guiding sheath, a 0.014F marker wire (Boston
Scientific Corporation, Natick, MA, USA) was advanced to the
carotid artery. A magnified diagnostic angiogram was per-
formed and the diameter and length of the stenosis was
measured by reference to the marker wire. A cerebral protec-
tion device (FilterWire Ex or Ez; Boston Scientific Corpora-
tion) was carefully navigated through the stenotic lesion and
placed in the distal cervical internal carotid artery. Pre-
dilatation of the carotid atherosclerotic lesion with a coronary
balloon (3e4 mm in diameter) was done in cases of >90%
stenosis. A self-expandable stent (Wallstent; Boston Scientific
Corporation; or Precise stent; Cordis Co. Bridgewater, NJ,
USA) was selected according to the dimensions of the diseased
carotid artery. Postdilatation with a balloon of 5e6 mm in
diameter was done in all cases. A control angiogram was
performed for the carotid artery and its intracranial branches to
confirm that the residual stenosis of the treated atherosclerotic
lesion was <30% and without intracranial vascular complica-
tion. Postprocedurally, all patients received the combination
therapy of aspirin (100 mg/day) and clopidogrel (75 mg/day)
for 3 months, and then aspirin monotherapy indefinitely.
Our primary outcome was the impact of dizziness on
quality of life. Therefore, two HRQoL questionnaires, the 36-
item Short-Form Health Survey (SF-36) and the Dizziness
Handicap Inventory (DHI), were used as outcome measures in
the current study.2.4. Medical outcome study SF-36The SF-36, originally developed for the Rand Corporation's
Health Insurance Experiment,11,12 is a 36-item, self-
administered generic questionnaire for the measurement of
HRQoL over the previous 4 weeks. The SF-36 has eight do-
mains that reflect physical health, mental health, and the
impact of health on daily functioning: physical functioning
(PF, 10 items); role limitation due to physical problems (RP, 4
items); bodily pain (BP, 2 items); vitality (VT, 4 items);
general health perceptions (GH, 5 items); social functioning
(SF, 2 items); role limitation due to emotional problems (RE, 4
items); and mental health (MH, 5 items).
After summing up the Likert-scale items in the SF-36, each
scale was then standardized so that it ranged from 0 to 100,
with higher scores indicating better health status.13 The
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using a standard methodology that was followed by the In-
ternational Quality of Life Assessment Project.14 The Cron-
bach a coefficient values of internal consistency for the
Chinese Version of SF-36 were all above the criteria of 0.7
(range, 0.72e0.90), as demonstrated in a previous study.142.5. DHIThe DHI, a disease-specific questionnaire, was developed to
measure self-perceived disability in dizzy patients.15 It is a 25-
item, self-rated questionnaire subdivided into three subscales:
nine items related to emotional well-being; nine items related to
functional activities; and seven items related to physical activ-
ities. Each question is answered “yes”, “sometimes”, or “no”
with scores of 4, 2, and 0 respectively, indicating how prob-
lematic or difficult each item is for the patient due to dizziness.
A total possible DHI score ranges from 0 (indicating no
disability) to 100 (indicating marked handicap). It has high in-
ternal consistency and good testeretest reliability.15,16 The
production of the Chinese version of the DHI also followed the
standard forward, backward, and pretest steps for instrument
translation.17 The Cronbach a coefficient values for the Chinese
version of DHI were all above the criteria of 0.7 (range,
0.79e0.87) with good testeretest reliability.18
Both questionnaires were taken 1 week prior to CAS as the
baseline value, and follow-up studies were done at 1 month
and 6 months postprocedurally.2.6. Statistical analysisTable 1
Demographic data of patients (n ¼ 41) and normal controls (n ¼ 20).
Patients Controls p
n % n %
Age (y), mean ± SD 73.3 ± 10.5 70.3 ± 9.3 0.729*
Sex (male) 34 83 17 85 0.837**
Hypertension 33 80.5 17 85 0.667**
DM 6 14.6 4 20 0.595**
Stroke or TIA 12 29.3 6 30 0.935**
CAD 7 17.1 4 20 0.780**
Hyperlipidemia 6 14.6 4 20 0.595**
Smoke 12 29.3 7 35 0.650**
Stenosis
L 15 36.6
R 26 63.4
Degree of stenosis
Mean ± SD 77.7 ± 10.8
Range 60e95%
*Student t test; **Chi square test.
CAD ¼ coronary artery disease; DM ¼ diabetes mellitus; L ¼ left; R ¼ right;
SD ¼ standard deviation; TIA ¼ transient ischemic attack.SPSS version 16.0 for Windows (SPSS Inc., Chicago, IL,
USA) was used for statistical analysis. Descriptive data are
presented as mean ± standard deviation and range for all
variables. The eight SF-36 dimensions were scored from
0 (worst possible health status) to 100 (best possible health
status), by coding, summating, and transforming its relevant
item scores according to the SF-36 manual.13 The scores of
total scale and subscales (physical, functional, and emotional)
of each participant were calculated by summing up each score
on the DHI.15 The Wilcoxon rank-sum test was used for be-
tween group analyses. Because the DHI and SF-36 scores were
not normally distributed, nonparametric comparisons among
the three times test were done with the Friedman test. For post
hoc analyses, we used the Wilcoxon rank-sum test with
Bonferroni correction. A p value 0.05 was considered to be
the threshold of statistical significance for those without post
hoc analysis. For those needing post hoc analysis with Bon-
ferroni correction, p  0.025 (0.05/2) was considered to be the
threshold of statistical significance.
3. Results
From January 2009 to December 2011, CAS was per-
formed in a total of 178 patients with severe internal carotid
artery stenosis, 61 of whom complained of dizziness. Of these
61 patients, 20 were dropped because of loss of follow-up (17cases) or periprocedural complications (3 cases). Thus, 41
(67.2%, 34 male, mean age: 73.3 ± 10.5 years, range: 47e87
years) who fulfilled both the inclusion and exclusion criteria
were left to form the basis of this study. No peri- or post-
procedural complications, such as embolic stroke, hyper-
perfusion, or intracranial hemorrhage, developed during the
follow-up period in these 41 patients.
By definition, dizziness was present in all patients. Twelve
(29.3%) patients had previous minor stroke or TIA, 33
(80.5%) patients had hypertension, and diabetes and hyper-
lipidemia occurred in six (14.5%) patients. Table 1 shows the
demographic data of all patients.
Compared with normal controls, patients with carotid ste-
nosis had worse baseline general HRQoL as evaluated by the
SF-36: PF, 54.9 ± 24.8 vs. 80.5 ± 15.5; RP, 20.1 ± 36.3 vs.
61.3 ± 40.1; BP, 76.4 ± 15.6 vs. 76.6 ± 17.1; GH, 55.3 ± 19.6
vs. 69.5 ± 18.1; VT, 48.4 ± 18.3 vs. 65.8 ± 15.2; SF,
56.7 ± 18.4 vs. 80.6 ± 16.5; RE, 27.6 ± 42.8 vs. 66.7 ± 34.5;
and MH, 62.3 ± 18.4 vs. 71.6 ± 15.4. CAS resulted in a
significant improvement in the general health status of these
patients. There was significant improvement in social function
1 month after CAS. After 6 months, there were significant
improvements in the RP, BP, GH, SF, and RE domains. Fig. 1
depicts changes of the SF-36 subscales 1 month and 6 months
after CAS.
The mean baseline total DHI score was 17.5 ± 12.2, which
was also significantly higher than that of the normal controls
(1.8 ± 2.1, p < 0.001). Similarly, the DHI also improved
significantly 6 months after CAS (11.7 ± 11.7, p ¼ 0.0027 vs.
baseline value). The mean baseline physical and functional
subscores were 5.0 ± 3.6 and 7.8 ± 5.1 respectively, which
improved significantly to 3.6 ± 3.4 and 5.6 ± 5.5 (both
p < 0.025 vs. baseline values) 1 month after CAS. These
improved further to 3.4 ± 3.4 and 4.9 ± 5.0 (both p < 0.01 vs.
baseline values) 6 months after CAS. There were no signifi-
cant interval changes for the emotional subscore. The results
of the total DHI score and its subscores are shown in Fig. 2.
Fig. 1. Generic health status during follow-up. The trend of the 36-item Short-
Form Health Survey scores from baseline to 6 months after carotid stenting of
the 41 patients is shown in Fig. 1. Higher scores indicate better quality of life.
There are significant differences in 5 of 8 subscales during the 6-month follow-
up. *p < 0.025. **p < 0.01, compared with baseline values. BP ¼ bodily pain;
GH ¼ general health perception; MH ¼ mental health perception;
PF ¼ physical functioning; RE ¼ role limitation due to emotional problems;
RP ¼ role limitation due to physical problems; SF ¼ social functioning;
VT ¼ vitality.
406 L.-C. Hsu et al. / Journal of the Chinese Medical Association 77 (2014) 403e408In order to clarify the effects of degree of carotid stenosis and
the history of previous stroke or TIA on the HRQoL in these
patients, post hoc analysis was used to examine the influence of
these factors. It showed that patients with more severe carotid
stenosis (80%) or prior history of minor stroke/TIA prior to
entry benefited most from CAS (Tables 2 and 3).
4. Discussion
In this study, we demonstrated that nonspecific dizziness was
present in a number of patients with hemodynamically signifi-
cant carotid stenosis. Furthermore, it had some negative impact
on HRQoL in these patients, which can be improved by CAS.Fig. 2. Disease-specific health status during follow-up. The trend of the
Dizziness Handicap Inventory scores from baseline to 6 months of the 41
patients after carotid stenting. Lower scores indicate better quality of life.
There are significant differences in total as well as physical and functional
subscales of the Dizziness Handicap Inventory during the 6-month follow-up.
*p < 0.025, **p < 0.01, ***p < 0.001, compared with baseline values.Dizziness is a prevalent and ubiquitous symptom in the
general population.2 Vestibular system diseases account for
over half of the cases.2 Cardiovascular (including cerebro-
vascular) disorders are important nonvestibular causes of
dizziness, especially those with a feeling of fainting or light-
headedness.3 Severe carotid stenosis, which causes distur-
bance of blood flow to the cranium, was present in 14e21% of
patients with nonspecific dizziness.4e6 Our hospital is a ter-
tiary referral center, which could partially explain the seem-
ingly higher proportion (one-third, 61/178) of patients
experiencing dizziness in our series.
Despite the high prevalence, patients with dizziness
frequently have difficulty describing and quantifying their
perception of dizziness.19 The self-rated questionnaire is a
useful tool to assess the perceived disability and treatment
outcome of dizziness. Two types of questionnaires have been
widely used for this purpose: a general health status ques-
tionnaire and a disease-specific questionnaire. The SF-36 is a
frequently used generic measurement of health status. This
multidimensional scale assesses the impact of disease on
wellbeing and functional status. DHI is a commonly used
disease-specific HRQoL instrument in patients with dizziness.
It has been used to assess the level of impairment in patients
experiencing dizziness20 as well as efficacy of the treatment
outcome.21 Previously, we have found a poor HRQoL, as
measured with the SF-36, in elderly Taiwanese patients
experiencing dizziness.22 In the present study, patients with
severe carotid stenosis who experienced dizziness had signif-
icantly lower scores than age- and sex-matched control in-
dividuals in all eight domains of the SF-36 parameters, except
for BP, as well as the total and three subscales of the DHI prior
to therapy. These results further confirmed the negative impact
of dizziness upon HRQoL.
Scores for our patients ranged from 33% to 88% of the
control values for 7 out of the 8 subscales of the SF-36, with
the lowest scores occurring in the RP (33%) and RE (41%)
domains. Similar findings were observed in two previous re-
ports in which the SF-36 was used to measure disability in
patients with dizziness.23,24 The severe limitations seen in
patients' physical and emotional well-being strongly un-
derscores the disabling nature of dizziness.
The high total DHI scale indicates that patients with carotid
stenosis are negatively affected by their dizzy symptom. Of the
three subscales of DHI, patients more frequently reported
functional and physical impairment than emotional distress.
These results are consistent with several other studies.20,24e26
Apparently, such patients may have suffered significant role
limitations due to physical problems and social function or
vitality.
Recently, CAS has emerged as an alternative therapeutic op-
tion in patients with significant carotid stenosis.7,8 However, little
is known about the impact of CAS on HRQoL. Our study shows
that CAS resulted in significant improvement in HRQoL in a
group of patients with both carotid stenosis and dizziness. Pre-
viously, there were only one nonrandomized and two large-scale
clinical trials evaluated quality of life after CAS versus carotid
endarterectomy.27e29 Substudies from SAPPHIRE (Stenting
Table 2
Baseline values and changes in health status scores 1 month and 6 months after carotid stenting in patients with <80% carotid stenosis versus patients with 80%
carotid stenosis.
<80% stenosis (n ¼ 20) 80% stenosis (n ¼ 21)
Baseline 1 mo 6 mo Baseline 1 mo 6 mo
P 5.9 ± 3.5 3.7 ± 3.7 4.1 ± 3.6 4.2 ± 3.6 3.5 ± 3.3 2.8 ± 3.0
E 5.3 ± 4.1 3.5 ± 4.3 4.3 ± 5.0 4.2 ± 4.5 4.5 ± 5.4 2.5 ± 3.2
F 8.8 ± 4.4 5.4 ± 5.7 5.5 ± 5.5* 6.9 ± 5.6 5.8 ± 5.3 4.3 ± 4.7*
T 19.9 ± 11.1 12.6 ± 12.8 13.9 ± 12.8 15.2 ± 13.0 13.8 ± 13.3 9.6 ± 10.5*
PF 57.5 ± 29.8 58.5 ± 27.0 55.3 ± 29.4 52.4 ± 19.3 50.7 ± 25.6 59.5 ± 24.1
RP 28.8 ± 39.9 37.5 ± 42.5 47.5 ± 45.1 11.9 ± 31.2 16.7 ± 31.9 34.5 ± 42.2
BP 78.9 ± 15.1 79.9 ± 18.6 78.2 ± 18.4 73.9 ± 16.1 85.0 ± 20.7 91.2 ± 10.6**
GH 52.6 ± 19.7 63.2 ± 25.7 59.3 ± 28.1 57.9 ± 19.7 56.1 ± 21.5 63.2 ± 18.4
VT 45.8 ± 19.3 51.8 ± 22.8 54.8 ± 23.0 50.9 ± 17.4 47.96 ± 20.5 55.7 ± 20.5
SF 56.3 ± 18.4 59.9 ± 15.4 60.0 ± 25.2 57.1 ± 18.8 69.1 ± 15.1* 69.1 ± 14.6*
RE 35.0 ± 45.2 51.7 ± 46.5 51.7 ± 50.1 20.6 ± 40.1 31.8 ± 40.1 49.2 ± 47.9
MH 60.0 ± 17.8 67.0 ± 21.7 61.2 ± 21.8 64.6 ± 19.0 65.7 ± 17.3 65.7 ± 19.7
*p < 0.01, **p < 0.001, compared to baseline values.
BP ¼ bodily pain; E ¼ emotional subscale of the Dizziness Handicap Inventory (DHI); F ¼ functional subscale of the DHI; GH ¼ general health perception;
MH ¼ mental health perception; P ¼ physical subscale of the DHI; PF ¼ physical functioning; RE ¼ role limitation due to emotional problems; RP ¼ role
limitation due to physical problems; SF ¼ social functioning; T ¼ total score of the DHI; VT ¼ vitality.
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Endarterectomy) and CREST (Carotid Revascularization End-
arterectomy vs. Stenting Trial) trials found that carotid revascu-
larization, particularly CAS, improved HRQoL as measured by
both generic (SF-36) and disease-specific instruments post-
procedurally.28,29 Both studies found that, compared to carotid
endarterectomy, CAS resulted in a significant improvement in
role physical function at 2 weeks and 1 month postprocedurally.
We also found that CAS resulted in improvement in general
HRQoL, especially the role limitations in physical and emotional
domains 1 month after the operation, which persisted for 6
months postprocedurally. Furthermore, in the present study, the
disease-specific questionnaire, the DHI for dizziness-related
handicap, also showed parallel improvement after CAS. Like-
wise, there were greater improvements in the physical and
functional subscales. Data from a subgroup analysis of the
CREST trial revealed that patients who suffered from aTable 3
Baseline values and changes in health status scores 1 month and 6 months after c
stroke/TIA.
No stroke (n ¼ 29)
Baseline 1 mo 6 mo
P 4.9 ± 3.5 3.6 ± 3.5 3.9 ± 3.6
E 4.5 ± 4.0 3.9 ± 4.8 3.8 ± 4.6
F 7.7 ± 4.9 5.3 ± 5.2* 5.1 ± 4.9*
T 17.0 ± 11.7 12.8 ± 12.6 12.9 ± 12.2
PF 58.3 ± 23.8 58.1 ± 24.2 59.3 ± 25.3
RP 26.7 ± 41.2 31.0 ± 38.2 42.2 ± 43.9
BP 77.3 ± 16.4 85.3 ± 17.3 82.4 ± 16.6
GH 57.2 ± 20.7 62.1 ± 22.7 60.8 ± 24.9
VT 50.3 ± 18.4 54.1 ± 19.0 56.7 ± 21.4
SF 59.1 ± 18.3 63.4 ± 15.6 64.7 ± 20.6
RE 35.6 ± 45.4 40.2 ± 43.9 47.1 ± 49.2
MH 62.6 ± 18.5 70.1 ± 17.4 63.2 ± 22.6
*p < 0.01, compared with baseline values.
BP ¼ bodily pain; E ¼ emotional subscale of the Dizziness Handicap Inventory (
MH ¼ mental health perception; P ¼ physical subscale of the DHI; PF ¼ physi
limitation due to physical problems; SF ¼ social functioning; T ¼ total score of tperiprocedural stroke had the worst health status.29 No major
periprocedural events occurred in our series. However, we found
that patients with a more severe degree of carotid stenosis and
prior stroke events benefited most from CAS. The fact that pa-
tients with 80% stenosis improved most could imply that the
more improved the perfusion status, the greater improvement
seen in dizziness. Further studies are needed to clarify the impact
of cerebral perfusion and previous stroke on quality of life.
The strengths of our study are that both generic and
disease-specific instruments were used in our patients, allow-
ing comparison with other trials and the recruitment of control
individuals for comparison. Nonetheless, our study did have
some limitations. First, vestibular function evaluation, e.g., the
caloric test, was not performed in our patients to exclude the
possibility of inner ear problems. However, patients with the
complaint of vertigo or prior history of vestibular disorders
were excluded from the present study to minimize the impactarotid stenting in patients with no prior history of stroke versus patients with
Stroke or TIA (n ¼ 12)
Baseline 1 mo 6 mo
5.2 ± 3.8 3.7 ± 3.4 2.1 ± 2.4
5.3 ± 5.0 4.3 ± 5.1 2.4 ± 3.1
8.1 ± 5.8 6.3 ± 6.3 4.3 ± 5.4*
18.6 ± 13.8 14.3 ± 14.3 8.8 ± 10.4*
46.7 ± 26.3 45.8 ± 29.8 52.9 ± 30.1
24.2 ± 9.7 16.7 ± 38.9 37.5 ± 44.6
74.3 ± 14.0 75.8 ± 23.8 91.1 ± 13.4*
50.1 ± 16.2 53.4 ± 25.6 62.5 ± 20.4
43.8 ± 17.9 39.2 ± 24.1 51.7 ± 22.2
51.0 ± 18.0 67.7 ± 16.4* 64.6 ± 21.9
38.3 ± 28.9 44.4 ± 45.7 58.3 ± 47.4*
61.7 ± 18.9 57.3 ± 21.6 64.3 ± 15.6
DHI); F ¼ functional subscale of the DHI; GH ¼ general health perception;
cal functioning; RE ¼ role limitation due to emotional problems; RP ¼ role
he DHI; VT ¼ vitality.
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parameters, such as cerebral blood flow, were not measured in
our study; it is premature to conclude the role of perfusion
change in dizzy patients. Third, because the sample came from
a veteran's hospital, male patients predominated. Fourth, dizzy
patients with symptomatic or asymptomatic carotid stenosis
who did not receive CAS were not recruited as controls
because almost all of them had received CAS. Fifth, about
one-third of the study participants were lost through follow-up
in the current study, which might affect the final results.
However, there were no significant differences in demographic
and available HRQoL data (data not shown), so it is less likely
to affect the final results. Finally, given the relatively small
sample size and intermediate follow-up period, our study
might have had insufficient detection of minor treatment ef-
fects at later periods of time.
In conclusion, our findings elucidate the role of hemody-
namically significant carotid stenosis in patients with dizzi-
ness. CAS results in improvement of HRQoL in these patients.
Large-scale studies are needed to test the hypothesis that
screening for carotid artery disease should be part of the
protocol to evaluate patients with dizziness.
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